Tony Reid is the chief executive officer and cofounder of EpicentRx, Inc. where he has built a fully integrated research and development team that has overseen the discovery and advancement of multiple therapeutic and device candidates into the clinic in several therapeutic areas from cancer to supportive care. Dr. Reid is professor emeritus at the University of California, San Diego, where he spent over two decades studying cancer gene therapy, oncolytic viral therapy and gastroenterology oncology. Before that, Dr. Reid was on faculty at Stanford University and directed a basic and clinical research program at the Palo Alto VA. Dr. Reid has managed an extensive portfolio of clinical trials, including more than 80 involving novel agents and early-phase studies. Dr. Reid served as the academic director for the Alzheimer’s Disease Cooperative Study, a collaborative effort between the National Institute on Aging (NIA) and U.C. San Diego.